Geode Capital Management’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Sell
42,234
-6,777
-14% -$54.7K ﹤0.01% 3753
2026
Q1
$404K Buy
49,011
+6,305
+15% +$51.1K ﹤0.01% 3663
2025
Q4
$470K Buy
42,706
+367
+0.9% +$5.43K ﹤0.01% 3606
2025
Q3
$756K Sell
42,339
-755
-2% -$19.2K ﹤0.01% 3483
2025
Q2
$898K Sell
43,094
-121
-0.3% -$2.53K ﹤0.01% 3360
2025
Q1
$751K Buy
43,215
+1,480
+4% +$30.7K ﹤0.01% 3400
2024
Q4
$797K Buy
41,735
+1,604
+4% +$48.9K ﹤0.01% 3440
2024
Q3
$2.7M Buy
40,131
+3,738
+10% +$88K ﹤0.01% 3032
2024
Q2
$375K Buy
36,393
+1,641
+5% +$17.7K ﹤0.01% 3673
2024
Q1
$375K Buy
34,752
+3,326
+11% +$36.5K ﹤0.01% 3710
2023
Q4
$240K Sell
31,426
-1,676
-5% -$12.1K ﹤0.01% 3874
2023
Q3
$283K Buy
33,102
+4,573
+16% +$46.1K ﹤0.01% 3833
2023
Q2
$314K Sell
28,529
-32,223
-53% -$394K ﹤0.01% 3835
2023
Q1
$803K Buy
60,752
+2,153
+4% +$31.8K ﹤0.01% 3443
2022
Q4
$738K Sell
58,599
-1,635
-3% -$80.8K ﹤0.01% 3503
2022
Q3
$5.83M Buy
60,234
+20,126
+50% +$2.3M ﹤0.01% 2592
2022
Q2
$3.71M Buy
40,108
+6,449
+19% +$913K ﹤0.01% 2856
2022
Q1
$7.24M Buy
33,659
+1,023
+3% +$239K ﹤0.01% 2576
2021
Q4
$11.2M Buy
32,636
+11,727
+56% +$4.53M ﹤0.01% 2371
2021
Q3
$7.47M Buy
20,909
+686
+3% +$256K ﹤0.01% 2673
2021
Q2
$7.81M Buy
20,223
+15,781
+355% +$5.85M ﹤0.01% 2635
2021
Q1
$2.23M Buy
+4,442
New +$2.28M ﹤0.01% 3209

Other funds holding TIL

Geode Capital Management's TIL Position: Q2 2026 in Review

Geode Capital Management reduced its Instil Bio (TIL) stake by 14% in Q2 2026, selling an estimated $54.7K and leaving 42,234 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #3753.

Geode Capital Management first reported a position in TIL in Q1 2021 and has held it in 22 quarters since. The position peaked at $11.2M in Q4 2021. 24 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • Geode Capital Management held 42,234 shares of Instil Bio worth $325K as of Q2 2026.
  • Geode Capital Management sold 6,777 Instil Bio shares in Q2 2026, an estimated $54.7K.
  • Instil Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3753 holding.
  • Geode Capital Management first reported a position in Instil Bio in Q1 2021 and has held it in 22 quarters since.
  • Geode Capital Management's Instil Bio position peaked at $11.2M in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.